Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital Post author:Sam Post published:January 31, 2018 Post category:BioPharma The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace You Might Also Like <b>ENDECE</b> Opens San Francisco Office February 12, 2017 Biotech Startup Bonanza Continues as Emerges With $30 Million September 18, 2017 Harvard???s Ph.D., A Leader In Alzheimer???s Disease Genetics, Joins Cerevance???s Advisory Board October 11, 2017
Harvard???s Ph.D., A Leader In Alzheimer???s Disease Genetics, Joins Cerevance???s Advisory Board October 11, 2017